In this article, we will discuss Durvalumab (Dosage-2). So, let’s get started.
ES-SCLC
- Patients with a body weight of 30 kg and more: 1,500 mg in combination with chemotherapy* every 3 weeks (21 days) for 4 cycles, followed by 1,500 mg every 4 weeks as a single agent